|
Please enjoy these articles. Click on the title to read the
entire article.
Please feel free to forward these to your friends. Also, please
remember to keep us in mind should you have a friend in need
of legal counsel with an injury claim.
In
this issue:
Starbucks Lawsuit Gets Conditional Class Status
A federal judge has granted conditional class-action status to a lawsuit filed by a Starbucks employee who claimed the coffee chain violated wage laws by failing to pay managers overtime. The conditional class covers all people who worked as managers from Jan. 15, 2006 to the present. Starbucks has faced various wage-related suits during the last year, including one in which a California court ordered the company to pay $100 million in tips and interest to baristas who were required to share tips with their supervisors. Melissa Allison, Seattle Times 04/25/2009
Study Links Ovary Removal to Health Risks
A new study has found increased health risks for women who elect to have their healthy ovaries removed during hysterectomy procedures. According to the study, to be published in the journal Obstetrics & Gynecology, women whose ovaries were removed were more likely to develop life threatening conditions including coronary heart disease and lung cancer. About half of the 600,000 women who undergo hysterectomies each year also have their ovaries removed. Deborah L. Shelton, LA Times 04/21/2009
Pharmaceutical Companies Warned About Internet Ads
The Food and Drug Administration warned major drug manufacturers last month that their Google search ads must contain information of potential risks, or be removed from the site. Industry executives argue that the 95-character limit does not allow for the warning information, and that a “one-click” rule should apply, meaning if the information is only one click away from the page the ad is on, they should be in compliance. An agency spokesperson said there is no such provision. Stephanie Clifford, The New York Times 04/16/2009
Quest Settles Whistle-Blower Claims
The Justice Department announced Wednesday that Quest Diagnostics will pay $302 million to a settle whistleblower claims alleging that a Quest subsidiary knowingly sold faulty diagnostic test kits. According to allegations, Nichols Institute Diagnostics continued to market its parathyroid test kits despite knowledge that the test sometimes produced elevated results. Under the settlement, the whistleblower will receive about $45 million. Reuters, Reuters 04/15/2009
|
